WHY YOU SHOULD NOT BUY THE SPACEX IPO

The SpaceX IPO may be pitched as the moonshot of the decade, but Wall Street’s “biggest IPO ever” script usually has a funny way of making issuers, insiders, and underwriters rich before ordinary long-term buyers get their turn. In our latest contrarian breakdown, we look past the confetti and ask the only question that matters: who is this deal really for? From first-day IPO pops to lockup expirations, thin floats, and the ugly history of marquee listings, this is a reminder that the smartest move may be skipping the launch-day circus and waiting for the post-hype hangover.